EPA乙酯
EPA乙酯结构式
|
常用名 | EPA乙酯 | 英文名 | eicosapentaenoic acid ethyl ester |
|---|---|---|---|---|
| CAS号 | 73310-10-8 | 分子量 | 330.504 | |
| 密度 | 0.9±0.1 g/cm3 | 沸点 | 417.0±34.0 °C at 760 mmHg | |
| 分子式 | C22H34O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 103.1±24.0 °C |
| 中文名 | EPA乙酯 |
|---|---|
| 英文名 | Ethyl 5,8,11,14,17-icosapentaenoate |
| 英文别名 | 更多 |
| 密度 | 0.9±0.1 g/cm3 |
|---|---|
| 沸点 | 417.0±34.0 °C at 760 mmHg |
| 分子式 | C22H34O2 |
| 分子量 | 330.504 |
| 闪点 | 103.1±24.0 °C |
| 精确质量 | 330.255890 |
| LogP | 7.32 |
| 蒸汽压 | 0.0±1.0 mmHg at 25°C |
| 折射率 | 1.496 |
| 储存条件 | -20°C |
| RTECS号 | JX3835000 |
|---|
|
Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats.
Food Funct. 2(7) , 386-94, (2011) Deposition of amyloid β peptide (Aβ) into the brain causes cognitive impairment. We investigated whether prescription pre-administration of n-3 fatty acids improves cognitive learning ability in young... |
|
|
Usefulness of colon targeted DHA and EPA as novel diabetes medications that promote intrinsic GLP-1 secretion.
J. Control. Release 132(2) , 99-104, (2008) Glucagon-like peptide-1 (GLP-1) is a gut-derived peptide secreted from intestinal L-cells and now considered as an ideal diabetic medicine. Recently, it was reported that the unsaturated fatty acid al... |
|
|
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Am. J. Hematol. 83(6) , 437-45, (2008) Newly described lipoxygenase (LOX)-generated lipid mediators, that is, resolvins and protectins as well as lipoxins, are both anti-inflammatory and proresolving. We aimed to determine whether these li... |
| Ethyl 5,8,11,14,17-icosapentaenoate |
| ethyl icosa-5,8,11,14,17-pentaenoate |
| 5,8,11,14,17-Eicosapentaenoic acid, ethyl ester |
| eicosapentaenoic acid ethyl ester |
